New drug combo shows promise for tough head and neck cancers
Disease control
Completed
This study tested a combination of two drugs, niraparib and dostarlimab, in 10 people with head and neck cancer that had come back or spread. The goal was to see if the combination could shrink tumors or slow the cancer. Participants had to be able to swallow pills and have no ot…
Phase: PHASE2 • Sponsor: Trisha Wise-Draper • Aim: Disease control
Last updated May 17, 2026 02:59 UTC